Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Aharon

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Clinical Psychopharmacology|February 1, 2000
Attention deficit-hyperactivity disorder may be a risk factor for treatment-emergent tardive dyskinesia induced by risperidoneH Silver, N Aharon, M Schwartz
Physical Review Letters|January 31, 2014
General scheme for the construction of a protected qubit subspaceN Aharon, M Drewsen, A Retzker
International Clinical Psychopharmacology|August 6, 1999
The effect of augmentation with moclobemide on symptoms of schizophreniaH Silver, N Aharon, N Hausfater, et al.
International Clinical Psychopharmacology|September 19, 2000
Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled studyH Silver, I Barash, N Aharon, et al.
Physical Review Letters|June 28, 2011
Fully distrustful quantum bit commitment and coin flippingJ Silman, A Chailloux, N Aharon, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Clinical Psychopharmacology|February 1, 2000
Attention deficit-hyperactivity disorder may be a risk factor for treatment-emergent tardive dyskinesia induced by risperidoneH Silver, N Aharon, M Schwartz
Physical Review Letters|January 31, 2014
General scheme for the construction of a protected qubit subspaceN Aharon, M Drewsen, A Retzker
International Clinical Psychopharmacology|August 6, 1999
The effect of augmentation with moclobemide on symptoms of schizophreniaH Silver, N Aharon, N Hausfater, et al.
International Clinical Psychopharmacology|September 19, 2000
Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled studyH Silver, I Barash, N Aharon, et al.
Physical Review Letters|June 28, 2011
Fully distrustful quantum bit commitment and coin flippingJ Silman, A Chailloux, N Aharon, et al.
Pageof 1